Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)

Invivyd (IVVD) reported Cash from Investing Activities of -$11000.0 for Q2 2025, up 92.36% quarter-over-quarter from -$144000.0 in Q1 2025.

Invivyd (IVVD) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Invivyd has reported Cash from Investing Activities for 5 years, with the latest figure at -$11000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$155000.0 (down 10.71% YoY), and the FY2025 full-year result was -$155000.0, down 10.71% from the prior year.
  • Cash from Investing Activities for Q2 2025 stood at -$11000.0, up from -$144000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $137.9 million in Q4 2021, with the low at -$188.6 million in Q3 2021.
  • Historically, Cash from Investing Activities has averaged -$65933.3 across 5 years, with a median of -$5000.0 in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 200.65% — and 2023, when it soared 191835.29%.
  • Invivyd's Cash from Investing Activities stood at $137.9 million in 2021, then slumped by 200.65% to -$138.8 million in 2022, then surged by 156.13% to $77.9 million in 2023, then plunged by 99.99% to $5000.0 in 2024, then sank by 320.0% to -$11000.0 in 2025.
  • The last three Cash from Investing Activities figures came in at -$11000.0 (Q2 2025), -$144000.0 (Q1 2025), and $5000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Invivyd 168.41 Mn -58.28 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Jun 30, 2025 -11,000.00
Mar 31, 2025 -144,000.00
Mar 31, 2025 -144,000.00
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 -5,000.00
Sep 30, 2024 -5,000.00
Mar 31, 2024 -140,000.00
Mar 31, 2024 -140,000.00
Dec 31, 2023 77.92 Mn
Dec 31, 2023 77.92 Mn
Sep 30, 2023 95.14 Mn
Sep 30, 2023 95.14 Mn
Jun 30, 2023 32.60 Mn
Jun 30, 2023 32.60 Mn
Mar 31, 2023 75.04 Mn
Mar 31, 2023 75.04 Mn
Dec 31, 2022 -138.81 Mn
Dec 31, 2022 -138.81 Mn